A

Ahmed, N., Giorgakoudi, K. ORCID: 0000-0002-5925-1846, Usuf, E., Okomo, U., Clarke, E., Kampmann, B., Le Doare, K. and Trotter, C. (2020). Potential cost-effectiveness of a maternal Group B streptococcal vaccine in The Gambia.. Vaccine, 38(15), pp. 3096-3104. doi: 10.1016/j.vaccine.2020.02.071

B

Bawden, D. and Robinson, L. (2011). Pharmaceutical Information: A 30-Year Perspective on the Literature. Annual Review of Information Science and Technology, 45(1), pp. 63-119. doi: 10.1002/aris.2011.1440450109

C

Charani, E., Ahmad, R. ORCID: 0000-0002-4294-7142, Rawson, T. M., Castro-Sanchèz, E., Tarrant, C. and Holmes, A. H. (2019). The Differences in Antibiotic Decision-making Between Acute Surgical and Acute Medical Teams: An Ethnographic Study of Culture and Team Dynamics. Clinical Infectious Diseases, 69(1), pp. 12-20. doi: 10.1093/cid/ciy844

F

Ferriani, S. ORCID: 0000-0001-9669-3486, Lazerson, M. H. and Lorenzoni, G. (2020). Anchor entrepreneurship and industry catalysis: The rise of the Italian Biomedical Valley. Research Policy, 49(8), 104045.. doi: 10.1016/j.respol.2020.104045

H

Hills, E., Rosenberg, J., Banfield, N. and Harding, C. ORCID: 0000-0002-5192-2027 (2020). A multidisciplinary approach to the implementation of non-pharmacological strategies to manage infant pain. Infant, 16(2), pp. 78-81.

K

Kavusan, K. and Frankort, H. T. W. ORCID: 0000-0002-0022-1570 (2019). A behavioral theory of alliance portfolio reconfiguration: Evidence from pharmaceutical biotechnology. Strategic Management Journal, 40(10), pp. 1668-1702. doi: 10.1002/smj.3041

N

Newham, M., Seldeslachts, J. and Banal-Estanol, A. (2018). Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry (18/03). London, UK: Department of Economics, City, University of London.